Eli Lilly and Company: Hypercholesterolemia trials
The registry lists 10 Hypercholesterolemia studies with Eli Lilly and Company as lead sponsor. 3 are open to participants now and 5 have results posted.
Phase 1 3Phase 2 4Phase 3 2No phase 1(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study of VERVE-102 (LY4636581) in Adults With or at High Risk for Cardiovascular DiseaseRecruitingNCT07839936Phase 2
- Phase 1b Study of VERVE-201 in Patients With Refractory HyperlipidemiaRecruitingNCT06451770Phase 1
- Long-term Follow-up of Participants Dosed With an Investigational Gene Editing Therapy for Cardiovascular DiseaseEnrolling by invitationNCT06112327
- A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary HypercholesterolemiaTerminatedNCT02260648Phase 3Results posted
- A Study of Evacetrapib (LY2484595) in Japanese Participants With Primary HypercholesterolemiaTerminatedNCT02260635Phase 3Results posted
- A Study of LY3015014 in Participants With High CholesterolCompletedNCT01890967Phase 2Results posted
- A Study of LY3015014 in Healthy Participants With High CholesterolCompletedNCT01671085Phase 1Results posted
- A Study of LY2484595 in Patients With High LDL-C or Low HDL-CCompletedNCT01105975Phase 2Results posted
- A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular DiseaseCompletedNCT05398029Phase 1
- A Study in People With High CholesterolCompletedNCT00133380Phase 2